{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:28:13Z","timestamp":1794608893081,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of breast cancer (BC) cases among transgender males undergoing gender-affirming mastectomy (GAM) and the future BC risk for this population are not well established. This scoping review aimed to explore breast cancer incidence rates before and after GAM in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following the Arskey and O\u2019Malley framework, the search was conducted in Embase and PubMed using keywords \u201cgender-affirming surgery\u201d and \u201cbreast cancer.\u201d The initial search resulted in 405 articles, with 36 articles imported to Covidence for the screening and selection phase. The articles were limited to the United States alone and within the last 10 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For final inclusion, 13 articles were identified (11 observational\/retrospective cohort studies and 2 case studies). Across all the studies, 42 cases of atypia, 6 cases of ductal carcinoma\n                      <jats:italic>in situ<\/jats:italic>\n                      (DCIS), 1 case of Paget\u2019s disease, and 10 cases of invasive ductal carcinoma (IDC) were reported. Nine studies reviewed routine GAM surgical specimens (3869 cases), identifying 42 cases of atypia, 5 cases of DCIS, 1 case of Paget\u2019s disease, and 3 cases of IDC. Seven invasive carcinomas and one DCIS case were detected pre-GAM during screening and involved concurrent treatment from breast and plastic surgery teams.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Standardization and best-practice screening protocols, including breast imaging before GAM and pathology performed on specimens collected during GAM, are needed. A shared decision-making approach and clinical coordination, including breast and plastic surgery for patients who receive a breast cancer diagnosis while pursuing GAM, can help achieve oncologic and cosmetic goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18156-1","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T19:20:03Z","timestamp":1756408803000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast Cancer Incidence Among Patients Undergoing Chest Masculinization Surgery: A Scoping Review"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-1920","authenticated-orcid":false,"given":"Crystal","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesong","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Stranix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"18156_CR1","unstructured":"Herman JL, Flores AR, O\u2019Neill KK. How Many Adults and Youth Identify as Transgender in the United States? The Williams Institute, 2022. Retrieved 29 January 2025 at https:\/\/williamsinstitute.law.ucla.edu\/publications\/trans-adults-united-states\/."},{"key":"18156_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.21037\/tau.2019.04.09","volume":"8","author":"IT Nolan","year":"2019","unstructured":"Nolan IT, Kuhner CJ, Dy GW. Demographic and temporal trends in transgender identities and gender confirming surgery. Transl Androl Urol. 2019;8:184\u201390. https:\/\/doi.org\/10.21037\/tau.2019.04.09.","journal-title":"Transl Androl Urol."},{"issue":"4 Suppl 4","key":"18156_CR3","doi-asserted-by":"publisher","first-page":"S332","DOI":"10.1097\/SAP.0000000000003083","volume":"88","author":"N Parmeshwar","year":"2022","unstructured":"Parmeshwar N, Song S, Alcon A, Kim EA. The incidence of breast cancer after gender-affirming mastectomy in transmen. Ann Plast Surg. 2022;88(4 Suppl 4):S332\u20136. https:\/\/doi.org\/10.1097\/SAP.0000000000003083.","journal-title":"Ann Plast Surg"},{"key":"18156_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.mayocp.2023.12.006","volume":"99","author":"A Suarez","year":"2024","unstructured":"Suarez A, Bisschops J, Lampen-Sachar K. Breast cancer screening recommendations for transgender patients: a review. Mayo Clin Proc. 2024;99:630\u20139. https:\/\/doi.org\/10.1016\/j.mayocp.2023.12.006.","journal-title":"Mayo Clin Proc"},{"key":"18156_CR5","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2024\u20132025. American Cancer Society; 2024. Retrieved 29 January 2025 at https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf"},{"key":"18156_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","journal-title":"Int J Soc Res Methodol"},{"key":"18156_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"18156_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41379-020-00675-9","volume":"34","author":"GM Baker","year":"2021","unstructured":"Baker GM, Guzman-Arocho YD, Bret-Mounet VC, et al. Testosterone therapy and breast histopathological features in transgender individuals. Mod Pathol. 2021;34:85\u201394. https:\/\/doi.org\/10.1038\/s41379-020-00675-9.","journal-title":"Mod Pathol"},{"key":"18156_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/trgh.2019.0040","volume":"4","author":"GM Baker","year":"2019","unstructured":"Baker GM, Pyle ME, Tobias AM, et al. Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology. Transgend Health. 2019;4:326\u201330. https:\/\/doi.org\/10.1089\/trgh.2019.0040.","journal-title":"Transgend Health"},{"key":"18156_CR10","doi-asserted-by":"publisher","first-page":"e4092","DOI":"10.1097\/GOX.0000000000004092","volume":"10","author":"CJ Boyd","year":"2022","unstructured":"Boyd CJ, Blasdel G, Rifkin WJ, Guth AA, Axelrod DM, Bluebond-Langner R. Gender-affirming mastectomy with concurrent oncologic mastectomy. Plast Reconstr Surg Glob Open. 2022;10:e4092. https:\/\/doi.org\/10.1097\/GOX.0000000000004092.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"3 Suppl 3","key":"18156_CR11","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/SAP.0000000000003175","volume":"88","author":"MK Bruce","year":"2022","unstructured":"Bruce MK, Joseph WJ, Grunwaldt L, Nguyen VT, De La Cruz C. Transgender mastectomy: incidence of high-risk pathologic findings and the need for postoperative cancer surveillance. Ann Plast Surg. 2022;88(3 Suppl 3):S148\u201351. https:\/\/doi.org\/10.1097\/SAP.0000000000003175.","journal-title":"Ann Plast Surg"},{"key":"18156_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.5858\/arpa.2019-0316-OA","volume":"144","author":"A Hernandez","year":"2020","unstructured":"Hernandez A, Schwartz CJ, Warfield D, et al. Pathologic evaluation of breast tissue from transmasculine individuals undergoing gender-affirming chest masculinization. Arch Pathol Lab Med. 2020;144:888\u201393. https:\/\/doi.org\/10.5858\/arpa.2019-0316-OA.","journal-title":"Arch Pathol Lab Med"},{"key":"18156_CR13","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1245\/s10434-024-15319-4","volume":"31","author":"AC Istl","year":"2024","unstructured":"Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS. Tumors, treatments, and trust: cancer characteristics, outcomes, and screening uptake in transgender and gender-diverse patients. Ann Surg Oncol. 2024;31:5560\u20139. https:\/\/doi.org\/10.1245\/s10434-024-15319-4.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"18156_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/trgh.2023.0011","volume":"10","author":"M Kolbow","year":"2023","unstructured":"Kolbow M, Cohen J, Prathibha S, Marmor S, Buckley MC, Hui JYC. Incidental atypia in patients undergoing chest masculinization surgery: an observational series. Transgend Health. 2023;10(3):297\u2013301. https:\/\/doi.org\/10.1089\/trgh.2023.0011.","journal-title":"Transgend Health"},{"key":"18156_CR15","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1245\/s10434-024-16005-1","volume":"31","author":"RL McCaffrey","year":"2024","unstructured":"McCaffrey RL, James AJ, Torres-Guzman RA, et al. Incidence of high risk and malignant pathological findings in transgender and gender diverse individuals undergoing gender-affirming mastectomy. Ann Surg Oncol. 2024;31:8086\u201392. https:\/\/doi.org\/10.1245\/s10434-024-16005-1.","journal-title":"Ann Surg Oncol"},{"key":"18156_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41379-018-0117-4","volume":"32","author":"VF Torous","year":"2019","unstructured":"Torous VF, Schnitt SJ. Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery. Mod Pathol. 2019;32:346\u201353. https:\/\/doi.org\/10.1038\/s41379-018-0117-4.","journal-title":"Mod Pathol."},{"key":"18156_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ajcp\/aqac123","volume":"159","author":"EA Wolters","year":"2023","unstructured":"Wolters EA, Rabe KE, Siegel L, Butts J, Klein ME. Histopathologic features of breast tissue from transgender men and their associations with androgen therapy. Am J Clin Pathol. 2023;159:43\u201352. https:\/\/doi.org\/10.1093\/ajcp\/aqac123.","journal-title":"Am J Clin Pathol"},{"key":"18156_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/tbcr-22-14","volume":"3","author":"N Bhagat","year":"2022","unstructured":"Bhagat N, Lautenslager L, Hadad I. A case report of gender-affirming mastectomy in a transgender individual with breast cancer. Transl Breast Cancer Res. 2022;3:27. https:\/\/doi.org\/10.21037\/tbcr-22-14.","journal-title":"Transl Breast Cancer Res."},{"key":"18156_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jadpro.2019.10.4.6","volume":"10","author":"A Fehl","year":"2019","unstructured":"Fehl A, Ferrari S, Wecht Z, Rosenzweig M. Breast cancer in the transgender population. J Adv Pract Oncol. 2019;10:387\u201394. https:\/\/doi.org\/10.6004\/jadpro.2019.10.4.6.","journal-title":"J Adv Pract Oncol."},{"key":"18156_CR20","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. Cancer stat facts: female breast cancer. National Cancer Institute. Retrieved 29 January 2025 at https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"18156_CR21","doi-asserted-by":"publisher","first-page":"e1738","DOI":"10.1097\/GOX.0000000000001738","volume":"6","author":"M Lane","year":"2018","unstructured":"Lane M, Ives GC, Sluiter EC, et al. Trends in gender-affirming surgery in insured patients in the United States. Plast Reconstr Surg Glob Open. 2018;6:e1738. https:\/\/doi.org\/10.1097\/GOX.0000000000001738.","journal-title":"Plast Reconstr Surg Glob Open."},{"key":"18156_CR22","unstructured":"Goethals A, Menon G, Rose J. Mastectomy. In: StatPearls.  StatPearls Publishing, Treasure Island, Fl, 2025. Retrieved 29 January 2025 at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538212\/."},{"key":"18156_CR23","unstructured":"Gender Confirmation Center. FTM\/N top surgery FAQ. Retrieved 29 January 2025 at https:\/\/www.genderconfirmation.com\/ftm-faq\/"},{"key":"18156_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","volume":"5","author":"MS Irwig","year":"2017","unstructured":"Irwig MS. Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 2017;5:301\u201311. https:\/\/doi.org\/10.1016\/S2213-8587(16)00036-X.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18156-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:09:39Z","timestamp":1765289379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18156-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18156"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18156-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this article have no commercial interest or financial disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}